Hyperliquid News Today: Hyperliquid's 0x9ee Whale Makes $241M in Bold ETH and ASTER Wagers
- Hyperliquid's largest ZEC short position incurred $21M in unrealized losses amid crypto market volatility. - HYPE token fell below key levels as liquidity challenges worsened after a $5M market maker loss from Popcat manipulation. - Whale address 0x9ee holds $241M in ETH/XRP long positions and a 3x ASTER short with mixed $13.7M unrealized gains/losses. - Abraxas Capital shifted from ASTER shorting to long positions, generating $750K profits amid shifting market sentiment. - HYPE faces technical breakdown
Hyperliquid's largest
The DEX's liquidity strains have intensified following a recent incident where its market maker, Hyperliquid Provider (HLP), suffered a $5 million loss. This event involved a Popcat (POPCAT) trader who reportedly spread $3 million across 19 wallets to artificially boost bid prices near $0.21 before opening $30 million in long positions.
At the same time, Hyperliquid's ecosystem has witnessed increased activity from large holders across several tokens. One address, tagged "0x9ee," has become the largest long position holder in ETH and
Other significant participants are also adjusting their Hyperliquid strategies. Abraxas Capital, through addresses 0x5b5 and 0xb83, has shifted from shorting ASTER to accumulating long positions, now holding $8.16 million in ASTER with $750,000 in unrealized gains.
HYPE, Hyperliquid's token, is under further downward pressure as technical signals worsen. The token has dropped below its 200-day exponential moving average (EMA) and
The DEX's recent suspension of its
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BCH has surged by 35.79% since the beginning of the year, reflecting the overall positive sentiment in the market.
- Bitcoin Cash (BCH) fell 0.1% in 24 hours but rose 35.79% year-to-date, outperforming peers. - Sustained 7-day (7.55%) and 1-month (9.1%) gains highlight growing institutional and retail confidence. - Market adoption in DeFi and low-cost transactions, plus macroeconomic optimism, drive BCH's long-term appeal. - Analysts predict continued growth as BCH's ecosystem matures and on-chain activity rises.
Solana's Sharp Drop: Causes Behind the Fall and Future Prospects for Investors
- Solana's 30% price drop in late 2025 contrasts with strong on-chain metrics like 400ms finality and $35.9B DEX volume, but declining user engagement and rising NVT ratios signaled overvaluation. - Macroeconomic factors including high interest rates and institutional caution reduced speculative demand, with ETF inflows favoring staking products over direct price support. - Whale accumulation and RWA growth (up 350% YoY) suggest strategic buying during dips, though active address recovery and NVT normaliza

The Increasing Expenses of Dementia Treatment and Their Influence on Healthcare Investment Prospects
- Global dementia cases surge to 55M in 2025, projected to triple to 139M by 2050 due to aging populations and Alzheimer's rise. - U.S. dementia costs hit $781B in 2025, with Medicare/Medicaid covering $164B and families paying $52B out-of-pocket. - Home healthcare and AI caregiver tech markets grow rapidly (10-17% CAGR), reaching $381B and $5.3B by 2033-2032 respectively. - Dementia biotech faces risks but attracts $3.1B in Q3 2025 venture funding (+70.9% QoQ), despite $161M losses at Alector/Denali. - St
